Table 1.
Characteristics of the patients
| Characteristic | All Patients (n = 100) | Clinic Visit from the Onset of Symptoms | ||
|---|---|---|---|---|
| < 7 Days (n = 23) | 8-14 Days (n = 58) | > 14 Days (n = 19) | ||
| Median age (IQR) – year | 52 (44–64) | 52 (44–64.25) | 52 (44–64) | 47 (43.75–64.75) |
| Male – no./total no. (%) | 43 (43) | 6 (26.1) | 25 (43.1) | 12 (63.2) |
| Available laboratory results – no. (%) | ||||
| COVID-19 IgM/IgG antibodies | 80 (80) | 14 (60.9) | 51 (87.9) | 15 (79.0) |
| COVID-19 IgM antibodies | 74 (74) | 13 (56.5) | 49 (84.4) | 12 (63.2) |
| COVID-19 IgG antibodies | 72 (72) | 8 (34.8) | 49 (84.4) | 15 (79.0) |
| Lymphocytopenia | 51 (50) | 15 (65.2) | 32 (55.2) | 4 (21.1) |
| Thrombocytopenia | 13 (13) | 2 (08.7) | 9 (15.5) | 2 (10.5) |
| RT-PCR positive result – no. (%) | 37 (37) | 11 (47.8) | 18 (31.0) | 7 (36.8) |
| Abnormalities on chest radiograph – no. (%) | 79 (79) | 17 (73.9) | 49 (84.5) | 14 (73.7) |
| Bilateral infiltrates | 76 (76) | 16 (69.6) | 47 (81.0) | 13 (68.4) |
| Unilateral infiltrates | 1 (01) | 1 (04.3) | 0 (0) | 0 (0) |
| Increased broncho-vascular markings | 2 (02) | 0 (0) | 2 (3.4) | 0 (0) |
| Signs and symptoms – no. (%) | ||||
| Fever | 90 (90) | 21 (91.3) | 53 (91.4) | 16 (84.2) |
| Cough | 89 (89) | 18 (78.3) | 54 (93.1) | 17 (89.5) |
| Dyspnea | 80 (80) | 21 (91.3) | 44 (75.9) | 15 (79.0) |
| Sore throat | 79 (79) | 18 (78.3) | 44 (75.9) | 17 (89.5) |
| Fatigue | 78 (78) | 15 (65.2) | 45 (77.6) | 19 (100) |
| Headache | 64 (64) | 18 (78.3) | 39 (67.2) | 7 (36.8) |
| Loss of taste | 53 (53) | 9 (39.1) | 30 (51.7) | 14 (73.7) |
| Loss of smell | 52 (52) | 7 (30.4) | 32 (55.2) | 13 (68.4) |
| Loss of appetite | 43 (43) | 9 (39.1) | 20 (34.5) | 14 (73.7) |
| Nausea and vomiting | 26 (26) | 5 (21.7) | 13 (22.4) | 8 (42.1) |
| Diarrhea | 23 (23) | 3 (13.0) | 11 (19.0) | 9 (47.4) |
| Rhinorrhea | 16 (16) | 4 (17.4) | 11 (19.0) | 1 (05.3) |
Notes: Data are summarized as no. or n (%), where n is the total number of patients with available data.
RT-PCR = reverse transcriptase polymerase chain reaction.